---
figid: PMC6169812__cshperspect-JCT-029322_F1
figlink: pmc/articles/PMC6169812/figure/A029322F1/
number: Figure 1
caption: New interactors of endothelial adherens junctions (AJs). Recently described
  interactors of VE-cadherin complexes and their functions in nascent (A) and stabilized
  (B) endothelial AJs are represented as discussed in the text. In addition, in (A),
  the binding of EGF receptor kinase substrate 8 (EPS8) to the AJ complex is shown
  to inhibit the phosphatidylinositol-3-kinase (PI3K)/AKT (protein kinase B) pathway,
  thus increasing VE-cadherin turnover at AJs () and maintaining dynamic AJs. Conversely,
  in stabilized AJs (B), the active PI3K/AKT pathway induces phosphorylation and cytoplasmic
  localization of the Yes-associated protein (YAP), which localizes to junctions and
  contributes to enhanced barrier function. As discussed in the text and shown in
  B, Rasip1 is required during stabilization of cell–cell contacts, but it is not
  necessary for their maintenance. The representation of the VE-cadherin domains interacting
  in trans (EC1-EC1) and in cis (EC1-EC2) are according to  and .
pmcid: PMC6169812
papertitle: Vascular Endothelial (VE)-Cadherin, Endothelial Adherens Junctions, and
  Vascular Disease.
reftext: Maria Grazia Lampugnani, et al. Cold Spring Harb Perspect Biol. 2018 Oct;10(10):a029322.
pmc_ranked_result_index: '84733'
pathway_score: 0.9002025
filename: cshperspect-JCT-029322_F1.jpg
figtitle: New interactors of endothelial adherens junctions (AJs)
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6169812__cshperspect-JCT-029322_F1.html
  '@type': Dataset
  description: New interactors of endothelial adherens junctions (AJs). Recently described
    interactors of VE-cadherin complexes and their functions in nascent (A) and stabilized
    (B) endothelial AJs are represented as discussed in the text. In addition, in
    (A), the binding of EGF receptor kinase substrate 8 (EPS8) to the AJ complex is
    shown to inhibit the phosphatidylinositol-3-kinase (PI3K)/AKT (protein kinase
    B) pathway, thus increasing VE-cadherin turnover at AJs () and maintaining dynamic
    AJs. Conversely, in stabilized AJs (B), the active PI3K/AKT pathway induces phosphorylation
    and cytoplasmic localization of the Yes-associated protein (YAP), which localizes
    to junctions and contributes to enhanced barrier function. As discussed in the
    text and shown in B, Rasip1 is required during stabilization of cell–cell contacts,
    but it is not necessary for their maintenance. The representation of the VE-cadherin
    domains interacting in trans (EC1-EC1) and in cis (EC1-EC2) are according to  and
    .
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TCF15
  - CCL21
  - CDH5
  - TRIO
  - CTNNB1
  - EPS8
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - AKT2
  - AKT3
  - AKT1
  - HEG1
  - RAB11A
  - OPTN
  - KRIT1
  - RASIP1
  - YWHAQ
  - CCM2
  - TERF2IP
  - YY1AP1
  - PDCD10
  - SRC
  - RHOD
  - Ga13-GTP
genes:
- word: EC2
  symbol: EC2
  source: hgnc_alias_symbol
  hgnc_symbol: TCF15
  entrez: '6939'
- word: EC1
  symbol: ECL
  source: hgnc_alias_symbol
  hgnc_symbol: CCL21
  entrez: '6366'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: TRIO
  symbol: TRIO
  source: hgnc_symbol
  hgnc_symbol: TRIO
  entrez: '7204'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: EPS8
  symbol: EPS8
  source: hgnc_symbol
  hgnc_symbol: EPS8
  entrez: '2059'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: HEG1
  symbol: HEG1
  source: hgnc_symbol
  hgnc_symbol: HEG1
  entrez: '57493'
- word: Rab11a-GTP
  symbol: RAB11A
  source: hgnc_symbol
  hgnc_symbol: RAB11A
  entrez: '8766'
- word: FIP2
  symbol: FIP2
  source: hgnc_alias_symbol
  hgnc_symbol: OPTN
  entrez: '10133'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: CCM1
  symbol: CCM1
  source: hgnc_prev_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Rasip1
  symbol: RASIP1
  source: hgnc_symbol
  hgnc_symbol: RASIP1
  entrez: '54922'
- word: 14-3-3
  symbol: 14-3-3
  source: hgnc_alias_symbol
  hgnc_symbol: YWHAQ
  entrez: '10971'
- word: CCM2
  symbol: CCM2
  source: hgnc_symbol
  hgnc_symbol: CCM2
  entrez: '83605'
- word: Rap1-GTP
  symbol: RAP1
  source: hgnc_alias_symbol
  hgnc_symbol: TERF2IP
  entrez: '54386'
- word: YAP
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: CCM3
  symbol: CCM3
  source: hgnc_prev_symbol
  hgnc_symbol: PDCD10
  entrez: '11235'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: VE-cadherin
  symbol: CDH5
  source: hgnc_symbol
  hgnc_symbol: CDH5
  entrez: '1003'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Rho
  symbol: Rho
  source: hgnc_alias_symbol
  hgnc_symbol: RHOD
  entrez: '29984'
chemicals:
- word: Ga13-GTP
  source: MESH
  identifier: C043055
diseases: []
---
